ASLAN PHARMACEUTICALS LIMITED

Analyst Reco. ASLAN Pharmaceuticals Limited

Equities

ASLN

US04522R2004

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-29 EDT			5-day change	1st Jan Change
0.457 ^USD	+10.04%		+0.44%	-12.47%

04-29	Asian Equities Traded in the US as American Depositary Receipts Open Week on Flat Note in Monday Trading	MT
04-26	Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5%	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Cuts ASLAN Pharmaceuticals Price Target to $9 From $17, Maintains Buy Rating	03-18	MT
Piper Sandler Cuts ASLAN Pharmaceuticals' Price Target to $10 From $15, Maintains Overweight Rating	03-13	MT
Roth MKM Initiates ASLAN Pharmaceuticals at Buy With $15 Price Target	23-05-31	MT
Piper Sandler Adjusts Price Target on ASLAN Pharmaceuticals to $3 From $4, Maintains Overweight Rating	23-02-27	MT
HC Wainwright Adjusts Price Target on ASLAN Pharmaceuticals to $4.50 From $7, Keeps Buy Rating	23-02-27	MT
Piper Sandler Adjusts Price Target on ASLAN Pharmaceuticals to $4 From $3, Reiterates Overweight Rating	22-09-16	MT
Piper Sandler Adjusts ASLAN Pharmaceuticals' Price Target to $3 from $8, Keeps Overweight Rating	22-05-23	MT
ASLAN PHARMACEUTICALS : Jefferies & Co Initiates Coverage on ASLAN Pharmaceuticals With Buy Rating, $8 Price Target	21-07-09	MT
ASLAN PHARMACEUTICALS : HC Wainwright Adjusts ASLAN Pharmaceuticals' Price Target to $8 from $5, Keeps Buy Rating	21-03-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer